You just read:

Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With Majority of Senior Subordinated Note Holders And Finalizing Details of Transaction to Effectuate a Significant Reduction in Debt. Business Operations Will Continue As Usual.

News provided by

Angiotech Pharmaceuticals, Inc.

Oct 01, 2010, 08:00 ET